Adult Acute Myeloblastic Leukemia Without Maturation (M1) Terminated Phase 2 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0028523 (Adult Acute Myeloblastic Leukemia Without Maturation (M1))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089388Cilengitide in Treating Patients With Acute Myeloid LeukemiaTreatment